{"transactions":[{"id":2855598,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":142573,"kind":"person","name":"MacDonald Stephen G.","position":1,"cik":"0001839189","reported_name":"MacDonald Stephen G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP FINANCE & ACCTG, TREASURER"}}],"security":"Stock Options","published_at":"2021-02-17T23:43:27.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":18849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable over a four-year period, with one-fourth of the shares of common stock underlying the options vesting on February 12, 2022, and the remainder vesting in twelve equal quarterly installments thereafter."}],"balance_after":18849,"derivative":{"exercise_price":4.04,"expiration_date":"2031-02-12","underlying":"Common Stock","underlying_shares":18849},"source":{"system":"sec-edgar","filing":"0001415889-21-000736","document":"form4-02172021_030216.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921000736/form4-02172021_030216.xml","form_type":"4"}}]}